The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resources where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
We are pleased to share that research presented at the 2014 HOPA Annual Conference by members Jennifer L Niccolai, PharmD and Danielle L Roman, PharmD, has been published in a recent Journal of Oncology Practice.Read it all here!
5th annual Oncology Pharmacy Practice Management Program—Registration now open!
Submit comments on the Draft ASHP-HOPA Guidelines - Roles and Responsibilities of the Pharmacy Technician in Ambulatory Oncology Pharmacy.
Oral Chemotherapy Resources: Practice tools, standards, and guidelines for use in the management of oral chemotherapy.
Three downloadable flyers you can give to patients to help them understand oncology pharmacy are now available.
Cabazitaxel (JEVTANA®, Sanofi-Aventis) approved a lower dose of cabazitaxel (20 mg/m2 every 3 weeks) (JEVTANA®, Sanofi-Aventis) in...
Copanlisib (ALIQOPA™, Bayer HealthCare Pharmaceuticals Inc.) for the treatment of adult patients with relapsed follicular lymphoma who...
Mvasi (bevacizumab-awwb, Amgen Inc.) as a biosimilar to Avastin (bevacizumab, Genentech Inc.). Mvasi is the first biosimilar approved in...
Gemtuzumab Ozogamicin (Mylotarg, Pfizer Inc.) newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and for treatment...
Save the date - March 21–24, 2018 - Denver, Colorado.
September 15-16, 2017, at the Chicago Marriott O'Hare. Registration is open.
BCOP Programming: Specialty Sessions & Updates Course
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.